Federated Hermes, Inc. Voyager Therapeutics, Inc. Transaction History

Federated Hermes, Inc.

$50.2 Billion
Q2 2025

A detailed history of Federated Hermes, Inc. transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 317 shares of VYGR stock, worth $1,708. This represents 0.0% of its overall portfolio holdings.

Number of Shares

317

Holding current value

$1,708

% of portfolio

0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$2.73 - $3.64 $865 - $1,153	317 New	317 $0
Q3 2024 Nov 13, 2024	SELL	$5.77 - $9.27 $16,248 - $26,104	-2,816 Reduced 0.51%	551,398 $3.23 Million
Q2 2024 Aug 08, 2024	BUY	$7.42 - $10.54 $19,573 - $27,804	2,638 Added 0.48%	554,214 $4.38 Million
Q4 2023 Jan 31, 2024	SELL	$6.28 - $8.81 $202,900 - $284,642	-32,309 Reduced 5.53%	551,576 $4.66 Million
Q3 2023 Nov 13, 2023	SELL	$7.55 - $11.25 $33,242 - $49,533	-4,403 Reduced 0.75%	583,885 $4.53 Million
Q2 2023 Aug 14, 2023	SELL	$6.94 - $13.99 $120,270 - $242,446	-17,330 Reduced 2.86%	588,288 $6.74 Million
Q1 2023 May 08, 2023	SELL	$6.0 - $10.78 $246 - $441	-41 Reduced 0.01%	605,618 $4.67 Million
Q4 2022 Feb 13, 2023	SELL	$4.94 - $6.61 $671 - $898	-136 Reduced 0.02%	605,659 $3.69 Million
Q3 2022 Nov 14, 2022	SELL	$5.57 - $7.47 $40,393 - $54,172	-7,252 Reduced 1.18%	605,795 $3.59 Million
Q2 2022 Aug 15, 2022	SELL	$4.82 - $10.09 $58,003 - $121,423	-12,034 Reduced 1.93%	613,047 $3.62 Million
Q1 2022 May 13, 2022	SELL	$2.75 - $9.44 $712 - $2,444	-259 Reduced 0.04%	625,081 $4.76 Million
Q4 2021 Feb 14, 2022	SELL	$2.47 - $5.55 $232,446 - $522,299	-94,108 Reduced 13.08%	625,340 $1.7 Million
Q3 2021 Nov 15, 2021	BUY	$2.63 - $4.12 $108,153 - $169,426	41,123 Added 6.06%	719,448 $1.89 Million
Q2 2021 Aug 16, 2021	BUY	$3.94 - $5.44 $1.6 Million - $2.2 Million	404,893 Added 148.08%	678,325 $2.8 Million
Q1 2021 May 13, 2021	SELL	$4.61 - $9.04 $164,719 - $323,008	-35,731 Reduced 11.56%	273,432 $1.29 Million
Q4 2020 Feb 12, 2021	SELL	$7.15 - $12.28 $1,537 - $2,640	-215 Reduced 0.07%	309,163 $2.21 Million
Q3 2020 Nov 12, 2020	BUY	$10.01 - $13.75 $494,844 - $679,731	49,435 Added 19.02%	309,378 $3.3 Million
Q2 2020 Aug 13, 2020	SELL	$8.05 - $14.21 $1.75 Million - $3.1 Million	-217,915 Reduced 45.6%	259,943 $3.28 Million
Q1 2020 May 13, 2020	SELL	$6.8 - $14.66 $3.73 Million - $8.03 Million	-547,964 Reduced 53.42%	477,858 $4.37 Million
Q4 2019 Feb 14, 2020	BUY	$12.82 - $16.85 $3.64 Million - $4.79 Million	284,022 Added 38.29%	1,025,822 $14.3 Million
Q3 2019 Nov 14, 2019	BUY	$16.31 - $28.29 $3.82 Million - $6.62 Million	234,022 Added 46.09%	741,800 $12.8 Million
Q2 2019 Aug 14, 2019	BUY	$19.18 - $27.88 $9.73 Million - $14.1 Million	507,369 Added 124051.1%	507,778 $13.8 Million
Q1 2019 May 10, 2019	SELL	$8.0 - $19.66 $26,592 - $65,349	-3,324 Reduced 89.04%	409 $8,000
Q4 2018 Feb 13, 2019	BUY	$8.59 - $18.05 $28,037 - $58,915	3,264 Added 695.95%	3,733 $35,000
Q3 2018 Nov 13, 2018	SELL	$17.11 - $21.74 $1,283 - $1,630	-75 Reduced 13.79%	469 $9,000
Q2 2018 Aug 10, 2018	SELL	$16.76 - $23.92 $4,558 - $6,506	-272 Reduced 33.33%	544 $11,000
Q1 2018 May 09, 2018	SELL	$16.16 - $31.31 $17,485 - $33,877	-1,082 Reduced 57.01%	816 $15,000
Q4 2017 Feb 14, 2018	BUY	$12.26 - $25.88 $23,269 - $49,120	1,898	1,898 $0

Others Institutions Holding VYGR

# of Institutions

119

Shares Held

32.8M

Call Options Held

32.9K

Put Options Held

22.7K

View Full List

About Voyager Therapeutics, Inc.

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $208M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

More about VYGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Voyager Therapeutics, Inc. Transaction History